Internal Medicine, Hematology & Oncology · Hershey, PA
NPI
1538401880
Since 2013
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
500 University Dr, Mc A410
Hershey, PA, 17033
Phone (717) 531-6585
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
376 services
Medicare patients, 2024
99
Average age 72
Drug cost, 2024
$2.9M
816 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Myles S Nickolich was code 99214 (office e&m - established), 169 times for 66 patients. In total Myles S Nickolich billed 376 services in 13 codes, and Medicare paid $31K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 169 | 66 | $63.88 | $11K |
| 99215 Office E&M - Established | Facility | 108 | 33 | $105.02 | $11K |
| 99233 Hospital E&M - Subsequent | Facility | 34 | 13 | $89.37 | $3,039 |
| 99232 Hospital E&M - Subsequent | Facility | 22 | 11 | $59.95 | $1,319 |
| 99205 Office E&M - New | Facility | 11 | 11 | $125.05 | $1,376 |
By year: 2022 $36K for 421 services; 2023 $32K for 370 services; 2024 $31K for 376 services.
Medicare prescription drug claims, 2024
In 2024, the drug Myles S Nickolich prescribed most often to Medicare patients was Acyclovir, with 90 prescriptions and refills. In total Myles S Nickolich wrote 816 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 90 | 136 | 22 | $1,153 |
| Venclexta Venetoclax | 58 | 58 | Under 11 | $125K |
| Levofloxacin Generic | 53 | 59 | Under 11 | $466 |
| Imatinib Mesylate Generic | 50 | 50 | Under 11 | $5,812 |
| Tamsulosin Hcl Generic | 28 | 28 | Under 11 | $55.9 |
| Posaconazole Generic | 27 | 27 | Under 11 | $27K |
| Allopurinol Generic | 26 | 38 | Under 11 | $227 |
| Sprycel Dasatinib | 25 | 25 | Under 11 | $280K |
| Amlodipine Besylate Generic | 23 | 29 | Under 11 | $35.43 |
| Jakafi Ruxolitinib Phosphate | 23 | 23 | Under 11 | $469K |
| Ondansetron Hcl Generic | 19 | 19 | Under 11 | $201 |
| Xospata Gilteritinib Fumarate | 18 | 18 | Under 11 | $498K |
| Eliquis Apixaban | 17 | 23 | Under 11 | $13K |
| Dapsone Generic | 17 | 19 | Under 11 | $564 |
| Omeprazole Generic | 16 | 20 | Under 11 | $60.57 |
Brand drugs: 256 claims; generic drugs: 560 claims; opioid claims: 13.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Myles S Nickolich were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.